Newer macrolides as empiric treatment for acute Q fever infection

Antimicrob Agents Chemother. 2001 Dec;45(12):3644-6. doi: 10.1128/AAC.45.12.3644-3646.2001.

Abstract

The effectiveness of newer macrolides in acute Q fever for 113 patients was recorded. The mean times to defervescence were 2.9 days for doxycycline and 3.3, 3.9, 3.9, and 6.4 days for clarithromycin, roxithromycin, erythromycin, and beta-lactams, respectively (P < 0.01 for macrolides versus beta-lactams). We conclude that macrolides may be an adequate empirical antibiotic therapy for acute Q fever.

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Antibodies, Bacterial / analysis
  • Coxiella burnetii / drug effects
  • Female
  • Humans
  • Lactams
  • Macrolides
  • Male
  • Middle Aged
  • Q Fever / diagnosis
  • Q Fever / drug therapy*
  • Q Fever / microbiology
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents
  • Antibodies, Bacterial
  • Lactams
  • Macrolides